Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-15

Clinical Trial Update: A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is evaluating whether Vicadrostat in combination with Empagliflozin improves outcomes in people with heart failure and is currently rec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Empagliflozin (empagliflozin)
  • Vicadrostat

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Heart Failure | Phase 3 | Status: RECRUITING